Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorouracil sustained-release implant for prevention of relapse and metastasis after gastric adenocarcinoma surgery
ChiCTR-TRC-08000264Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluorouracil in gastric adenocarcinoma (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Safety assessment, Tumor-free survival time and 1 more. Started Sep 2006; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-08000264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000264.